今开:1.93 | 昨收:1.91 |
最高:2.13 | 最低:1.92 |
涨停价:0.0 | 跌停价:0.0 |
总市值:3.95847185E8 |
产业链观察03-22 23:51
#药闻简讯# Daiichi Sankyo和$Esperion(ESPR)$公告EMA CHMP对NILEMDO和NUSTENDI的标签更新采取了积极的意见,建议批准作为降低低密度脂蛋白胆固醇(LDL-C)和心血管风险的治疗方法。查看全文
Esperion(ESPR)02-14 21:45
$Esperion(ESPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001172661-24-000918 Act: 34 Size: 103 KB 网页链接查看全文
Esperion(ESPR)02-27 20:25
$Esperion(ESPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-007035 Act: 34 Size: 253 KB 网页链接查看全文
Esperion(ESPR)04-12 04:25
$Esperion(ESPR)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-015824 Act: 34 Size: 2 MB 网页链接查看全文
Esperion(ESPR)04-12 04:25
$Esperion(ESPR)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-015820 Act: 34 Size: 20 MB 网页链接查看全文
Esperion(ESPR)02-14 23:55
$Esperion(ESPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001315863-24-000253 Act: 34 Size: 89 KB 网页链接查看全文
Esperion(ESPR)02-10 05:15
$Esperion(ESPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0000814133-24-000033 Act: 34 Size: 4 KB 网页链接查看全文
Esperion(ESPR)03-16 04:45
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011490 Size: 21 KB 网页链接查看全文
Esperion(ESPR)03-16 04:45
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011485 Size: 6 KB 网页链接查看全文
丰硕创投04-17 17:44
$Esperion(ESPR)$ 2024年1月4日,Esperio公司和第一三共欧洲公司宣布对其合作进行1.25亿美元的修改,并解决诉讼。这两者的合作源于2019年,在2023年3月15日的时候,第一三共欧洲公司不同意支付3亿美元的里程碑付款,双方争议点在心血管风险降低率这个指标,当时Esperion查看全文
智通财经APP获悉,Esperion Therapeutics(ESPR.US)披露日本第一三共欧洲子公司Daiichi Sankyo Europe(DSE)不同意其拖欠该公司的两种含bempedoic acid的降胆固醇药物的里程碑付款。截至发稿,Esperion盘后跌近54%,报1.72美元 Espierion... 网页链接
$Esperion(ESPR)$ ARS Annual Report to Security Holders Accession Number: 0001628280-24-015820 Act: 34 Size: 20 MB 网页链接
$Esperion(ESPR)$ DEF 14A Other definitive proxy statements Accession Number: 0001628280-24-015824 Act: 34 Size: 2 MB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011485 Size: 6 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011488 Size: 20 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011492 Size: 22 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011490 Size: 21 KB 网页链接
$Esperion(ESPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001628280-24-011494 Size: 20 KB 网页链接
$Esperion(ESPR)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001628280-24-007066 Act: 34 Size: 9 MB 网页链接
$Esperion(ESPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001628280-24-007035 Act: 34 Size: 253 KB 网页链接
$Esperion(ESPR)$ SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-24-023419 Act: 34 Size: 61 KB 网页链接